General Announcement::We enclose a communication pertaining to USFDA approval.

Issuer & Securities

Issuer/ Manager
JUBILANT PHARMA LIMITED
Securities
JUBILANTP US$300M4.875%N211006 - XS1493722299 - 4X7B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Jan-2018 20:38:49
Status
New
Announcement Sub Title
We enclose a communication pertaining to USFDA approval.
Announcement Reference
SG180130OTHRY5L6
Submitted By (Co./ Ind. Name)
Sanjay Bhartia
Designation
Chief Financial Officer
Effective Date and Time of the event
30/01/2018 17:00:00
Description (Please provide a detailed description of the event in the box below)
We enclose a communication pertaining to USFDA approval.

Attachments

JPL - USFDA approval - 30-01-2018.pdf
Total size =132K